Milwaukee Capital Partners Enhances Its Portfolio
Milwaukee Capital Partners LLC (MCP) is excited to announce its acquisition of MPP Group LLC in an all-cash transaction. This strategic acquisition opens doors for MCP in the pharmaceutical contract research and development sectors. MPP Group will remain headquartered at its current location, enabling continuity in operations while expanding its reach and offerings in an increasingly competitive market.
Advancements in Pharmacology
The acquisition signifies more than just a business move; it represents MCP's commitment to fostering innovation in pharmaceutical technology. By adding MPP Group to its portfolio, MCP not only solidifies its influence in the private equity landscape but also commits to driving significant advancements in the pharmaceutical research sector.
Significant Growth Opportunities Ahead
This acquisition allows for a substantial cash infusion, which will facilitate investment in specialized analytical services and broader capital projects. Thomas Kintis, Managing Partner of MCP, indicated that as more pharmaceutical development is repatriated to the U.S., MPP Group is uniquely positioned to connect with pharmaceutical and biotech companies both domestically and abroad, maximizing collaboration and opportunity.
Focus on Injectable Drug Development
MPP Group stands out as a leader in providing contract analytical services and product development, especially focusing on the development of injectable drug products. Their expertise spans analytical development, formulation validations, container screening, and thorough risk assessments related to elemental impurities. Their established reputation for personalized service and rigorous attention to detail makes them a valuable asset in the challenging contract services industry.
Strategically Located for Success
Situated in a prime area of scientific and soft manufacturing excellence, MPP Group benefits from access to a pool of highly talented scientists and engineers. This location draws talent from Illinois, Indiana, Michigan, Minnesota, and Wisconsin, providing MPP with the expertise needed to excel in drug development and manufacturing. Being near several prestigious universities further enhances their capability for innovation and collaboration.
The Vision of MPP Group
Founded in 2016 by Dr. Michal A. Major, who previously led Cambridge Major Laboratories, MPP Group was established to provide better access to testing and development for emerging pharmaceutical and biotech companies. Their strategic partnerships emphasize honesty and timely deliverables, ensuring that clients receive the focused attention they deserve. Their FDA-approved facility, spanning 35,000 square feet, is equipped with multiple laboratories featuring qualified instruments and ample space for expansion into sterile manufacturing.
Media Inquiries
For further information about Milwaukee Capital Partners and future investment opportunities, please contact Thomas Kintis. If you are seeking information regarding the services offered by MPP Group, reach out to Benjamin Nelson. For inquiries about CU Ventures, connect with Daniel Sem.
Frequently Asked Questions
What is the significance of MCP's acquisition of MPP Group?
The acquisition enhances MCP's capabilities in pharmaceutical contract research and development, allowing for growth and innovation in this sector.
Who will lead MPP Group following the acquisition?
Benjamin Nelson, Ph.D., will continue in his role as President and Head of Product Development, ensuring continuity in leadership.
What type of services does MPP Group offer?
MPP Group specializes in providing contract analytical services and product research focusing on injectable drug products and related development.
Where is MPP Group located?
MPP Group is located in a strategic area that affords access to talented scientists and engineers, enhancing their operational capabilities.
When was MPP Group established?
Founded in 2016, MPP Group was created to support emerging pharma and biotech companies with limited testing and development resources.
